Veronica Fuentes

FDA investigator

Appears on 22 documents from 2016 to 2026, mostly at sites in Georgia. Most often cites production record review (21 CFR 211.192).

22
Documents on file
4.5
Observations per 483
2016
First seen
2026
Most recent

What they cite most

From 99 observations

Activity by year

2016: 1, 2017: 2, 2018: 1, 2019: 3, 2020: 2, 2021: 2, 2022: 3, 2023: 2, 2024: 3, 2025: 1, 2026: 2

Where

Georgia 12 · North Carolina 3 · Kansas 2 · Missouri 2 · Alabama 1 · South Carolina 1

Is Veronica Fuentes coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

22 documents, newest first
FirmOpen
483 Fujifilm Diosynth Biotechnologies USA Inc.Mar 27, 2026 · Research Triangle Park, North Carolina
483 PTI Georgia, LLC dba Pharma Tech IndustriesJan 16, 2026 · Royston, Georgia
483 Winder Laboratories, LLCAug 5, 2025 · Winder, Georgia
483 Nephron Sterile Compounding CenterSep 25, 2024 · West Columbia, South Carolina
483 Purisys LLCMar 13, 2024 · Athens, Georgia
Amended 483 Baxter Healthcare CorporationFeb 9, 2024 · Marion, North Carolina
483 UNION AGENER, INC.Dec 15, 2023 · Augusta, Georgia

About this profile

What does Veronica Fuentes inspect?

Veronica Fuentes appears on 22 documents on file covering 20 sites, mostly in Georgia.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.100 and 21 CFR 211.198.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Veronica Fuentes is dated Mar 27, 2026.

FDA Investigator Veronica Fuentes: 483s & Inspections · FDA Intel